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Short title: Phosphorylation of latrophilin-1 




Latrophilin-1 is an Adhesion G protein-coupled receptor, which mediates the effect of α-
latrotoxin, causing massive release of neurotransmitters from nerve terminals and endocrine 
cells. Autoproteolysis cleaves latrophilin-1 into two parts: the extracellular N-terminal fragment 
(NTF) and the heptahelical C-terminal fragment (CTF). NTF and CTF can exist as independent 
proteins in the plasma membrane, but α-latrotoxin binding to NTF induces their association and 
G protein-mediated signaling. We demonstrate here that CTF in synapses is phosphorylated 
on multiple sites. Phosphorylated CTF has a high affinity for NTF and co-purifies with it on 
affinity columns and on sucrose density gradients. Dephosphorylated CTF has a lower affinity 
for NTF and can behave as a separate protein. α-Latrotoxin (and possibly other ligands of 
latrophilin-1) binds both to the NTF-CTF complex and to receptor-like protein tyrosine 
phosphatase σ, bringing them together. This leads to CTF dephosphorylation and facilitates 
CTF release from the complex. We propose that ligand-dependent phosphorylation-
dephosphorylation of latrophilin-1 could affect the interaction between its fragments and its 
functions as a G protein-coupled receptor.  
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Introduction 
Latrophilin (LPHN1, or ADGRL1 in the new nomenclature1) is a classical representative of 
Adhesion G protein-coupled receptors (Adhesion GPCRs). It was discovered due to its 
interaction with α-latrotoxin (α-LTX) from black widows spider venom2–5. Latrophilin was one of 
the first GPCRs to be recognized as an unusual receptor belonging to a new group, which is 
now known as Adhesion GPCRs.  
Adhesion GPCRs are a large family within the superfamily of GPCRs. They are ancient 
proteins, found in all vertebrates as well as in primitive and unicellular metazoans, and even in 
fungi (reviewed in Ref. 1). Adhesion GPCRs are thought to convert physical extracellular 
interactions into intracellular signaling and may have evolved to help cells communicate with 
the environment and with each other, a feature that could contribute to the evolution of 
multicellularity in metazoans. Adhesion GPCRs feature some unusual structural characteristics 
that clearly distinguish them from the rest of GPCRs: a long N-terminal extracellular domain 
which contains a variable number of very diverse cell-adhesion modules, a conserved 
extracellular “GPCR autoproteolysis-inducing” (GAIN) domain, which is unique to Adhesion 
GPCRs, and a long cytoplasmic C-terminal tail6. Autoproteolysis within the GAIN domain occurs 
in most members of this family and breaks the proteins into two parts: N-terminal fragment 
(NTF) and C-terminal fragment (CTF). The functional association and dissociation of the NTF 
and CTF have been first studied in LPHN14,7,8. 
The NTF does not have a transmembrane domain, but can anchor on the cell surface by 
forming a strong complex with the CTF4 or via an unknown membrane anchor7. In contrast, the 
CTF is essentially a classical GPCR9, with a very short N-terminal ectodomain (18 amino acids) 
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and a long cytosolic tail (~350 residues). The very N-terminal 7 amino acids of CTF (called a 
Stachel peptide) are important for the interaction between the NTF and CTF7,10,11. 
In LPHN1, the two fragments have been shown to behave as partially independent proteins on 
the cell surface7,8 (see also Discussion). All known ligands of LPHN1 (its natural agonist α-LTX 
and its physiological partners: teneurin-212, FLRT-313, and contactin-614) interact with its NTF. 
At least α-LTX and teneurin-2 induce NTF and CTF association and formation of large receptor 
complexes, generating intracellular signals7,8,12,15,16. α-LTX, a potent presynaptic neurotoxin 
that triggers strong release of neurotransmitters from neuronal and endocrine cells17, is the best 
known agonist for LPHN1 and is most useful to study LPHN1. First, it has the highest affinity 
for LPHN1 and does not dissociate from it during affinity chromatography under stringent 
conditions. Second, it is evolutionarily adapted to cause strong signaling, which cannot be 
achieved with more physiological ligands. Finally, most interesting facts about the LPHN1 
architecture and functions have been discovered due to the use of α-LTX17. However, wild-type 
α-LTX also forms Ca2+-permeable pores in biological membranes18, creating a technical 
problem when detecting intracellular signaling. Therefore, a mutant LTXN4C(19), which does not 
form membrane pores7,20, has been primarily used to study the LPHN1-mediated intracellular 
signaling. It has been shown7,20–25 that LTXN4C binding to the NTF induces its association with 
the CTF and stimulates a G-protein signaling cascade (Gαq → phospholipase C (PLC) → 
inositol(1,4,5)trisphosphate → release of stored Ca2+) and thus leads to potentiation of 
exocytosis.  
However, very little is still known about the regulation of the CTF signaling functions. In 
particular, GPCRs are known to be regulated by phosphorylation26–28, yet, to date, 
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phosphorylation of any Adhesion GPCRs was reported in one publication only29, where the 
application of a mechanical force to the NTF of CD97 (ADGRE5) was shown to cause 
phosphorylation of the CTF, which altered its intracellular coupling. This suggests that CTF 
phosphorylation may play an important role in Adhesion GPCR functions and needs to be 
carefully studied. 
Here, we demonstrate that the CTF of LPHN1 in neuronal nerve terminals is normally 
phosphorylated on multiple sites. We also show that the phosphorylated CTF species have a 
high affinity for the NTF and form stable complexes with it, while dephosphorylated CTF has a 
lower affinity for NTF and can exist separately from the NTF. The binding of α-LTX to the NTF 
induces NTF-CTF coupling and also recruits receptor-like protein tyrosine phosphatase σ 
(RPTPσ1) to the complex, leading to CTF dephosphorylation and a decrease in its affinity for 
the NTF. Our findings suggest that LPHN1 functioning as a two-subunit complex may be 
regulated by the phosphorylation of its CTF. This study provides a first glimpse into the role of 
phosphorylation in the dynamic structure of Adhesion GPCRs and calls for an in-depth 
investigation of this phenomenon. 
Experimental Procedures 
Materials 
The following primary antibodies were used to stain LPHN1 fragments and other proteins. NTF: 
rabbit polyclonal anti-peptide antibody PAL130 (immune IgG against 
CYAFNTNANREEPVSLAFPNP); affinity-purified rabbit polyclonal antibody RL1 (against the 
whole rat NTF)2. CTF: affinity purified rabbit polyclonal antibody R4 (against the cytosolic tail of 
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rat CTF)31; chicken polyclonal anti-peptide IgY CCT (against C-terminal peptide 
CEGPGPDGDGQMQLVTSL. Neurexin Iα: affinity-purified rabbit polyclonal anti-peptide 
antibody 116-1 (produced in-house against rat peptide CSANKNKKNKDKEYYV)31. Receptor-
like protein tyrosine phosphatase σ (RPTPσ1): goat polyclonal IgG against the extracellular 
fragment of mouse RPTPσ (R&D Systems). Antibodies recognizing phosphorylated amino 
acids: anti-phosphoserine mouse monoclonal antibody (16B4, Sigma-Aldrich); anti-
phosphotyrosine mouse monoclonal antibody (2C8, Sigma-Aldrich); anti-phosphothreonine 
rabbit monoclonal antibody (Sigma-Aldrich). All chemical reagents were from Sigma-Aldrich, 
unless otherwise stated. 
Fractionation of brain membranes 
Male Sprague-Dawley rats (150 g) were purchased from Charles River UK. In some 
experiments, male C57BL/6 mice (Charles River UK) were used in parallel with the LPHN1 
knockout mouse strain AG148, obtained in-house16 and back-crossed onto C57BL/6 
background. The brains were removed from animals within 30 s of Schedule 1 and 
homogenized with 10 strokes of a Potter-Elvehjem homogenizer (clearance 0.2 mm) in 0.32 M 
sucrose, 10 mM HEPES, pH 7.4, supplemented with protease inhibitors (see below). This Total 
Brain homogenate (TB) was centrifuged for 2 min, at 2,200 x g in a table-top centrifuge 
(Heraeus) to yield a pellet P1 (containing nuclei, large fragments of neuronal and glial cell 
bodies, and connective tissue) and a supernatant S1 (containing crude post-nuclear 
membranes: synapses, broken dendrites and axons, and somal cytosol and intracellular 
membranes). The S1 was further centrifuged for 20 min, at 12,000 x g using a Sorvall SS34 
rotor (Beckman) to yield pellet P2 (containing crude post-nuclear membranes and lacking somal 
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cytosol and intracellular membranes), and supernatant S2 (containing cytosol, somal vesicles, 
and broken membranes). P2 was further separated by 1 h centrifugation at 64,000 x g on step-
wise Ficoll gradients (7.5% and 12.5% Ficoll) to isolate synaptosomes32. The synaptosomes 
were recovered from the 7.5%/12% Ficoll interface. To remove the Ficoll, the synaptosomes 
were washed twice by resuspension/centrifugation in a physiological buffer containing (in mM): 
NaCl, 132; KCl, 5; MgSO4, 2.5; EGTA, 0.1; D-glucose, 10; HEPES, 20 (pH 7.4). To obtain 
synaptosomal plasma membranes (SPM), synaptosomes were osmotically lysed in 30 ml of 
ice-cold 10 mM Tris-HCl, pH 7.6, containing 50 µM CaCl2 and protease inhibitors. The lysate 
was subjected to three freeze/thaw cycles at –70 ºC, after which it was centrifuged for 1 h, at 
100,000 x g, at 4 ºC, to yield SPM and supernatant S3. S3 was used for synaptic vesicle 
purification. All membrane fractions were used for LPHN1 purification (see below).  
Affinity purification of LPHN1  
An α-LTX column was synthesized by immobilizing 1 mg of highly purified α-LTX33 on 1 mL of 
CNBr-activated Sepharose-4CL (Sigma-Aldrich). To optimize LPHN1 extraction, different 
detergents (Thesit, Triton X-100, or CHAPS) were tested. Respective membrane pellets were 
re-suspended in TBS buffer (50 mM Tris-HCl, pH 7.6, 0.2 M NaCl) containing 2 mM EDTA and 
2% detergent, incubated for 2 h, at 4ºC, then centrifuged for 20 min, at 20,000 x g and the 
supernatants were mixed with a 6X loading buffer for SDS-polyacrylamide gel-electrophoresis 
(SDS-PAGE) (see below). Thesit proved to be optimal for LPHN1 extraction and was used in 
all affinity chromatographies. All buffers also contained protease inhibitors: 104 mM AEBSF, 80 
μM aprotinin, 4 mM bestatin, 1.4 mM E-64, 2 mM leupeptin and 1.5 mM pepstatin A (Sigma-
Aldrich). As described under Results, a phosphatase inhibitors (PPI) cocktail (final 
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concentrations: 2 mM imidazole, 1 mM NaF, 1.2 mM sodium molybdate, 1 mM sodium 
orthovanadate, and 4 mM sodium tartrate dihydrate) (Sigma-Aldrich), or at least 100 mM 
activated sodium orthovanadate, was added where appropriate. The solubilized membranes 
were cleared by centrifugation for 20 min, at 20,000 x g and diluted 3-fold with TBS. Preparative 
affinity chromatography of LPHN1 was carried out on a freshly prepared 1-mL α-LTX-column; 
analytical purification of LPHN1 from the lysates obtained from different membrane fractions 
was conducted using 50 μL of the α-LTX-column. The lysates were incubated with the α-LTX 
column overnight, at 4ºC. The beads were then washed with 50 column volumes of TBS 
containing 0.2% Thesit (TBT), then with 20 column volumes of 0.5 NaCl in TBT and then eluted 
with 2 M NaCl in TBT or with SDS-PAGE Sample Buffer to ensure complete removal of LPHN1 
from the gel matrix.  
For additional LPHN1 purification, diluted high salt eluates from α-LTX affinity chromatography 
(or synaptosomes solubilized as described above) were incubated with 1 ml of wheat germ 
agglutinin (WGA)-Sepharose 4B (Sigma-Aldrich) for 16 h, at 4ºC. The gel was then extensively 
washed with 0.5 M NaCl in TBT, followed by elution with 100 mM N-acetylglucosamine or SDS-
containing sample buffer, as specified under Results. 
LPHN1 deglycosylation  
LPHN1 isolated by LTX affinity chromatography was resuspended in TBT containing 2 mM 
CaCl2 and treated with 10 mU of neuraminidase (Boehringer Mannheim) for 1 h, then denatured 
for 10 min with 1% SDS, supplemented with 1% Triton X-100 to neutralize SDS, and finally 
treated for 1 h with peptide:N-glycosidase F (PNGase, Boehringer Mannheim) and/or O-
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glycosidase (Calbiochem). All incubations were performed at 37ºC and stopped by adding 
SDS-PAGE Loading Buffer. 
Immunoprecipitation  
Purified LPHN1 was incubated with a chicken antibody against a rat CTF peptide (see above), 
overnight, at 4ºC, with rotation. Protein A-Sepharose 4B (Sigma-Aldrich) was added to this 
mixture and incubated for 2 h, at 4ºC. The beads were washed with 0.5 M NaCl in TBT and 
eluted with a 2x SDS sample buffer, before being heated for 30 min at 50ºC and loaded on an 
SDS-gel. 
Sucrose density gradients 
Sucrose density gradient centrifugation was performed essentially as described previously34. 
The gradients consisted of 10 layers of 8 to 17% (w/v) sucrose in TBT and an underlying 1 ml 
cushion of 30% sucrose. These step-wise gradients achieved perfect linearity after 
centrifugation, which was controlled by measuring the density of all fractions. 1-ml samples of 
solubilized membranes were loaded on the top of gradients, which were centrifuged for 16 h at 
165,000 x g in an SW40Ti rotor, at 4ºC. After centrifugation, 0.5-ml fractions were collected, 
starting from the bottom of the tube, and analyzed by SDS-PAGE and Western blotting.  
CTF dephosphorylation 
Purified native LPHN1 was treated at 37ºC for 1 h with 1 unit of a recombinant alkaline 
phosphatase (Sigma-Aldrich) in the presence of 5 mM Tris, pH 9.8, 1 mM MgCl2 and 0.1 mM 
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ZnCl2. Samples were collected at regular time intervals, titrated to pH 6.8, and analyzed by 
SDS-PAGE and Western blotting. PPI cocktail (see above) was used in some experiments.  
LPHN1 125I-iodination  
LPHN1 was purified from P2 membranes on an α-LTX-column in the presence of protease 
inhibitors and PPIs, as described above, and eluted from the column with TBT containing 2 mM 
EDTA and 2 M NaCl. The receptor was then desalted on a Bio-Gel P-10 column (Bio-Rad) 
equilibrated in TBT and concentrated to ~54 nM using centrifugal ultrafiltration units (Amicon 
Ultra-15, Merck), at 4°C. A 100-µL aliquot of this solution containing 1 µg of LPHN1 was mixed 
with 5 µL Na125I (18.5 MBq), 7.5 μL of 2.8 mM chloramine T and TBT to 150 µL, and incubated 
for 1 min, with periodic up-down pipetting. The reaction was stopped by the addition of 7.5 μL 
of 3.7 mM Na2S205 and 50 μL of 160 mM NaI in TBT, mixed and immediately loaded on the top 
of a Bio-Gel P-10 column pre-equilibrated in TBT containing 0.1% BSA. The column was eluted 
by sequential addition of 0.5 mL aliquots of TBT to the gel top and collection of respective 
fractions. Fractions (2-6) containing the radioactive protein were combined; protein recovery 
was about 90% in non-radioactive pilot experiments.  
LPHN1 32P-phosphorylation  
Synaptosomes (Syn) were isolated from rat brain cortex, as described above, resuspended in 
5 mL of buffer containing (in mM): NaCl, 140; KCl, 3; MgCl2; 1, CaCl2, 2; D-glucose, 5.6; 
HEPES-NaOH, 10, pH 7.4; and equilibrated at 23°C for 10 min, with constant oxygenation. The 
reaction was initiated by adding [32P]orthophosphate (18,5 MBq). The final concentrations of 
PO43- was 1 μM. The reaction proceeded for 1 h and was terminated by the addition of an equal 
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volume of ice-cold PBS containing 2% Triton X-100, 20 mM EDTA and PPIs. After a 2 h 
incubation at 4°C, solubilized proteins were cleared by centrifugation at 20,000 x g for 20 min, 
at 4°C. The lysate was diluted to 0.2% Thesit and incubated with a 50 μL LTX-column for 2 h, 
at 4°C; the column was washed and eluted with SDS Loading Buffer. The proteins were then 
resolved by SDS-PAGE and visualized by autoradiography and Western blotting. Prior to SDS-
PAGE, some samples were boiled for 5 min (see Results).  
[32P]-Phosphorylation of COS7 cells, transiently transfected with LPHN1 or an empty vector, 
was carried out by adding 32PO43- (18.5 MBq) to the culture medium 6 h after transfection, 
followed by overnight incubation at 37°C and 5% CO2. The cells were harvested from the plates 
in PBS containing 1% Thesit, incubated for 1 h, centrifuged at 20,000 x g, at 4°C, and the 
supernatants were analyzed by SDS-PAGE and Western blotting.  
SDS-gel electrophoresis 
Discontinuous SDS-PAGE was performed according to Laemmli35 using BioRad Mini-Protean 
II apparatus. Liquid protein samples were mixed with 2X-6X Loading Buffer, which contained 
100 mM dithiothreitol (DTT) (final concentration). Before loading onto gels, samples were 
heated for 2-5 min at 100ºC or for 30 min at 37-50ºC. To perform SDS-PAGE in the presence 
of urea, the resolving gel, stacking gel and loading buffer were supplemented with 
electrophoresis grade 8 M urea (Sigma-Aldrich). Protein samples containing urea were only 
heated to 37ºC. Electrophoresis was carried out at 100 V and, when the samples reached the 
resolving gel, at 150 V. 
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Prior to SDS-PAGE dilute samples were concentrated by protein precipitation, according to one 
of the following methods. Method 1: two volumes of a 1:1 chloroform/methanol mixture was 
added to one volume of sample, followed by thorough mixing and a brief centrifugation. The 
precipitate recovered from the solvent-water interface was washed once with methanol and 
then dried in air. Method 2: ice-cold trichloroacetic acid was added to samples to a final 
concentration of 10%, the mixture was left on ice for 20 min and then centrifuged for 30 min, at 
25,000 x g and 4ºC. After the removal of the supernatant, the pellet was washed with ice-cold 
acetone, then dried in air. Resulting sample pellets were dissolved in 1X Loading Buffer and 
heated as described above. 
Western blotting 
Proteins separated in SDS-gels were transferred onto polyvinylidene fluoride (PVDF) 
membranes, using a wet electrophoretic transfer unit, in a Tris-glycine buffer containing 20% 
methanol. The membranes were blocked using 5% non-fat milk (or 3% BSA), 0.1% Tween in 
PBS (PBST) overnight and washed 5 times with PBST. The blots were then incubated for 1 h 
with respective primary antibodies, washed 5 times with PBST and incubated for 1 h with 
matching horseradish peroxidase-conjugated secondary antibodies (Sigma-Aldrich). After 
additional 5 washes with PBST, the immunostained proteins were visualized using the 
enhanced chemiluminescence technique, as specified by the manufacturer (Millipore).  
The images were obtained by exposure to Kodak BioMax XAR film (Sigma-Aldrich) or digitally 
captured using a LAS-3000 gel imager at a maximal resolution (Fujifilm). Multiple exposures 
were taken to determine the linear response range of the film/detection camera for each protein. 
Radioactive proteins were detected by exposure of the blots to Kodak BioMax XAR film over 
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16-72 h; 32P exposure was carried out at –70ºC using an intensifying screen. Exposed film was 
digitized by optical scanning at 600-1200 dpi resolution, in the transparency mode. Digitized 
images were analyzed by computer-aided densitometry using the image processing software 
Fiji (NHS). 
Affinity purification of anti-NTF and anti-CTF antibodies 
For affinity purification of RL1 and R4 antibodies, expression constructs were made containing, 
respectively, rat NTF (nucleotides 630–2957) fused with glutathione-S-reductase and rat CTF 
cytosolic tail (nucleotides 3976–4856) fused with dihydrofolate reductase. These constructs 
were expressed in E. coli, isolated by affinity chromatography on, respectively, a glutathione 
column and a Ni2+ column, separated by SDS-PAGE and transferred onto PVDF membranes. 
The membranes were blocked with 5% non-fat milk in PBST and incubated with the respective 
antisera overnight. After several washes with PBS, specific antibodies were eluted from the 
membranes with 0.5 M NaCl, 0.5 M glycine, pH 2.4, and neutralized with Tris base.  
Cell culture 
African green monkey kidney (COS7) and mouse neuroblastoma (NB2a) cell lines were 
maintained at 5% CO2, 37ºC, in multi-well plates (Nunc) in Dulbecco’s modified Eagle’s medium 
(Life Technologies, Inc.) containing 10% fetal bovine serum (NB2a cells were also 
supplemented with GlutamaxTM). Cells were grown to 80% confluence and split 1:6 every 2-3 
days. When passaging, the cells were detached using Trypsin-EDTA (0.05 %). Cells were 
transiently transfected with full-size LPHN1 in pcDNA3.17 using the SuperFect transfection 
reagent (Qiagen), according to the manufacturer’s protocol, and analyzed 24 h later. Stable 
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lines were generated in NB2a cells by FuGene6-aided transfection (Roche Diagnostics), 
followed by G418 (Invitrogen) selection and cell sorting (Becton Dickinson). Stably transfected 
NB2a cell lines were maintained in G418 (300 μg/mL). 
Protein phosphorylation bioinformatics 
The following Internet resources were used to predict phosphorylation consensus sites in the 
full CTF sequence: PhosphoSitePlus (https://www.phosphosite.org/homeAction.action)36, 
NetPhos 2.0 (http://www.cbs.dtu.dk/services/NetPhos-2.0/); NetPhos 3.1b 
(http://www.cbs.dtu.dk/services/NetPhos/); PhosphoMotif Finder 
(http://www.hprd.org/PhosphoMotif_finder); KinasePhos 
(http://kinasephos.mbc.nctu.edu.tw/predict.php) and some other. Potential phosphorylation 
sites detected by the software in the extracellular loops were disregarded.  
Reverse-transcription polymerase chain reaction (RT-PCR) 
Total RNA from NB2a cells was isolated using a High Pure RNA Isolation Kit (Roche). RNA 
concentration and purity was assessed with a Nanodrop 2000 spectrophotometer (Thermo 
Fisher Scientific). cDNA was synthesized using 1 μg total RNA and anchored oligo(dT)18 
primers with the Transcriptor First Strand cDNA Synthesis Kit (Roche). Expression profiles of 
RPTPS1, STIM1, STIM2, and β-actin mRNA were determined using quantitative RT-PCR (qRT-
PCR) performed on a LightCycler 480 (Roche) using SYBR GreenIMaster reaction mix (Roche) 
and specific primers designed using the Lasergene software (DNASTAR) (target gene 
RPTP1S, CCGCTATGTCCTCTTTGTGCTTGC / GCGGGGCTCTGAGTCCTTGCGTTT; 
housekeeping gene β-actin, TTCGCGGGCGACGATGC / GGGGCCACACGCAGCTCATT; 
control genes STIM1, CCGCCCTAACCCCGCCCACT / CCCCCTCAATCAGCCGATGGC and 
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STIM2 TCAGCCGGCAATGATAGCAAG / TGGAAAGCCCCAGTGGAGTTA). Reactions 
began with a 5 min preincubation at 95°C, followed by 40-45 cycles of 10 s at 95°C, 20 s at 
60°C, and 10 s at 72°C. A final elongation step at 72°C continued for 5 min. Fluorescence was 
measured once at 80°C during each cycle. Amplification of correct products was confirmed 
using the LightCycler melting temperature (Tm) analysis. Raw fluorescence data were analyzed 
using LinRegPCR quantitative PCR data analysis program37, which calculated the PCR 
efficiency for each reaction. The initial amount of target cDNA in a sample was determined 
using the following equation: N0 = Nt/EmeanCq, where N0 is the initial concentration in arbitrary 
fluorescent units; Nt is a fluorescence threshold; Emean is the mean reaction efficiency; and Cq 
is the quantification cycle threshold (when the reaction exceeds the initial concentration, N0). 
For each reaction, the baseline fluorescence was subtracted from the curve. The specificity of 
qRT-PCR was ascertained by including two controls with each reaction: 1 μL of undiluted total 
RNA (to test for residual genomic DNA) and 1 μL of nuclease-free water (to show the specificity 
of cDNA amplification).  
Statistical methods 
The numerical data presented in Figures or text are the means ± SD. The p value was 
calculated using a two-tailed heteroscedastic t-test, with Bonferroni correction in cases of 
multiple pair-wise comparisons. The number of independent experiments n was between 3 and 
12, and is demonstrated by individual data points in the diagrams. The following notation was 
used to denote statistical significance: NS (non-significant), p > 0.05; *, p < 0.05; **, p < 0.01; 
***, p < 0.001. All images are representative of a number of independent experiments (n = 3-
21), which all gave similar results; the specific n for each image is provided in Figure legends. 
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RESULTS 
The CTF is phosphorylated on multiple sites 
LPHN1 can be highly purified from rat brain membranes using an α-LTX affinity column2. To 
analyze possible post-translational modifications of the CTF, it was necessary to optimize its 
SDS-PAGE analysis (Fig. 1). As previously described4, in conventional SDS-PAGE, only the 
NTF can be fully resolved as a band with an apparent molecular mass of ~ 120 kDa, while the 
CTF aggregates and does not enter the gel (Fig. 1A, left). Inclusion of 8 M urea in SDS-gels 
and loading buffer4 allows CTF separation (Fig. 1A, middle). However, on SDS-urea gels both 
the NTF and CTF show abnormal mobility, appearing as diffuse, poorly resolved bands (Fig. 
1A, middle). Interestingly, SDS-PAGE samples containing urea must not be boiled to avoid 
carbamylation of proteins, while normal SDS-PAGE samples are routinely boiled. We 
hypothesized that it was sample boiling (rather than a lack of urea) that caused CTF 
aggregation on normal SDS-gels. Indeed, when LPHN1 sample was heated to 37-50ºC only, 
both of its fragments were perfectly resolved in normal SDS-gels containing no urea (Fig. 1A, 
right). Under these conditions, the NTF appeared as a defined band of 120 kDa, while the CTF 
migrated at 65-75 kDa. Furthermore, the CTF was now clearly resolved into at least 4 distinct 
bands (Fig. 1A, inset). The relative abundance of the major bands (CTF-a,b,c,d) varied between 
different samples (Fig.1B) (see below).  
The nature of the CTF bands was not immediately clear. One possibility was that, in addition to 
LPHN1, LTX-affinity columns could also pull down LPHN2 and 3. The three homologous CTFs 
could have different electrophoretic mobilities and could be recognized by our anti-CTF 
antibodies, giving rise to multiple bands. To rule out this possibility, we performed LTX-affinity 
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chromatography of solubilized P2 membranes from the brains of wild-type and LPHN1 knockout 
mice (Fig. 1C). This experiment demonstrated that mouse CTF had a similar migration pattern 
on SDS-gels as the rat protein, but our anti-CTF antibody did not recognize any proteins in the 
brains that lacked LPHN1 (Fig. 1C, arrowhead). This clearly indicated that the multiple bands 
stained by the anti-CTF antibody belonged to the CTF of LPHN1 only.  
The other possibility was that the CTF could be post-translationally modified, e.g. glycosylated 
or phosphorylated. Treatment of purified LPHN1 with a set of glycohydrolases (Fig. 2A) reduced 
the apparent molecular mass of NTF from 120 kDa to around 105 kDa. Glycosylation of the 
native NTF was confirmed by extended SDS-PAGE in a 4% gel (Fig. 2A, inset). However, there 
was no change in the migration profile of the CTF, indicating that it was probably not 
glycosylated (Fig. 2A). To test for possible phosphorylation, purified LPHN1 was treated with 
alkaline phosphatase, an enzyme that dephosphorylates proteins modified by all types of 
phosphorylation. As a result, the NTF migration was not affected (Fig. 2B), while the 
electrophoretic mobility of the upper three CTF bands gradually increased and all CTF 
eventually migrated as one thick band at the level of CTF-a or slightly lower (65 kDa, Fig. 2B, 
lane 4; Fig. 2C). The specificity of dephosphorylation reaction was confirmed by the inclusion 
of PPIs, which prevented the change in CTF migration pattern (Fig. 2B, lane 5). The 
phosphatase also affected the CTF bands when it was applied to solubilized brain membranes, 
indicating that the CTF bound to its normal partners was still accessible to phosphatases. 
Computer-aided densitometry (Fig. 2C) indicated that the optical density of the 
dephosphorylated CTF band, on average, matched the density of the combined original four 
CTF bands, proving that they all represented one protein with different degrees of 
phosphorylation. The apparent size of the dephosphorylated CTF-a corresponded to that of the 
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CTF from recombinant LPHN1 expressed in COS7 cells (Fig. 2D, lane 1), which traveled as a 
single band and had either no phosphorylation or a low degree of phosphorylation.  
However, even after 2 h exposure to a large concentration of alkaline phosphatase, the CTF 
dephosphorylation seemed to be incomplete, with a fainter secondary band appearing above 
the main CTF band (Fig. 2B, lane 4; 2D, lane 4). We hypothesized that this was due to a 
phosphate group (or groups) resistant to alkaline phosphatase, or to a different type of 
modification, e.g. palmitoylation. When this partially dephosphorylated CTF was treated with 
0.5 M hydroxylamine, which cleaves Cys-palmitoyl thioester linkages, the residual phospho-
band disappeared (Fig. 2D, lane 5). Hydroxylamine itself did not change the migration pattern 
of fully phosphorylated CTF (lane 6), but made it more susceptible to alkaline phosphatase 
(lane 7), indicating that CTF could indeed be S-palmitoylated.  
When CTF was dephosphorylated, its amount often decreased on the blots (Fig. 2D, lane2 vs. 
lanes 3-5), suggesting that the removal of phosphate groups could render the CTF susceptible 
to proteolytic degradation. However, this was unlikely, because all our buffers contained 
protease inhibitors, and the remaining dephosphorylated band appeared to be stable in 
solution. Moreover, we noticed (Fig. 2D, right) that CTF dephosphorylation greatly increased 
its SDS-resistant dimerization (arrowhead 2) and formation of higher complexes. When all CTF 
bands (including its aggregates, but excluding any fragments) were combined and normalized 
to NTF, no loss of CTF bands was observed (Fig. 2E). Thus, CTF dephosphorylation does not 
cause its degradation, but may induce it to form very stable complexes. 
The type of CTF phosphorylation was revealed by staining the protein with antibodies against 
phosphotyrosine, phosphothreonine, and phosphoserine (Fig. 2F, lanes 4, 6, 8). This showed 
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that all three types of phosphorylation were present in the CTF. Even the fastest migrating band 
(CTF-a) appeared to carry more than one phosphate group, on both Tyr and Ser residues (lanes 
4 and 8). The slow migrating bands (CTF-b,c,d) demonstrated differential phosphorylation, but 
most had all three types of phosphoamino acids and, thus, were phosphorylated on multiple 
sites. Analysis of the phosphorylation pattern (not shown) suggested that a minimum of 7 
phosphates could be present in the top band (CTF-d). Alkaline phosphatase treatment removed 
all phosphates from the CTF (Fig. 2F, lanes 3, 5, 7), but the fully dephosphorylated CTF 
migrated on the gel marginally lower than the partially phosphorylated CTF-a (Figs. 2B, D, F).  
To study the dynamics of CTF phosphorylation in nerve terminals, we used radioactive 
phosphate to evaluate the rate with which new phosphate groups could be incorporated into 
the CTF. For this purpose, we incubated freshly purified synaptosomes with [32P]-
orthophosphate for 1 h and then isolated the receptor on an α-LTX column in the presence of 
PPIs, to avoid LPHN1 dephosphorylation by cellular phosphatases. Pure LPHN1 was then 
separated by SDS-PAGE, transferred onto PVDF membrane and exposed to autoradiography 
film (Fig. 2G, lane 1). The following additional experiments were conducted in parallel: (1) after 
autoradiography, the 32P-labeled membrane was immunostained for CTF and NTF (Fig. 2G, 
lanes 3, 5); (2) the CTF blot was additionally exposed for a longer time to demonstrate the 
presence of CTF dimers (lane 4, arrowhead 2); (3) a similar sample of purified LPHN1 was 125I-
iodinated, resolved by SDS-PAGE, and autoradiographed to visualize the major proteins 
present in a LPHN1 preparation (lane 6); (4) some of the 32P- and 125I-labeled samples were 
boiled to identify the CTF (lanes 2, 7). These additional data (including electrophoretic mobility, 
amount present in purified sample and susceptibility to boiling) allowed us to unequivocally 
identify the 32P-phosphorylated bands present in purified LPHN1 (Fig. 2G, lane 1): the CTF-
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b,c,d bands (filled arrowhead, CTF) and the CTF dimer (filled arrowhead, 2); in addition, a small 
amount of a 48-kDa CTF degradation fragment and an unidentified P93 protein (asterisk) were 
present. Surprisingly, CTF contained relatively little incorporated 32P (compared to the P93 
contaminant, which was only visible by 32P autoradiography, but not by 125I autoradiography). 
Based on the relative abundance of the 32P-detected and immunostained CTF dimers (lanes 1 
and 4, respectively), we estimated the proportion of slow migrating CTF monomers (CTF-b,c,d) 
that were phosphorylated. Thus, in the absence of exogenous stimulation of LPHN1, no more 
than 16.1 ± 4.6% of its CTF exchanges its phosphate groups within 1 h. 
One unexpected observation from the above experiments was that the fast-migrating CTF-a 
band (or bands) in fact contained phosphate groups (on Tyr and Ser), but did not exchange 
them. This suggested that under the resting conditions, all or almost all LPHN1 CTF was 
phosphorylated and therefore this basal phosphorylation was unlikely to occur as a result of 
LPHN1 activation and subsequent desensitization. To support this hypothesis, we studied CTF 
phosphorylation in COS7 cells, which originate from kidney fibroblasts, do not demonstrate 
neuronal features and are unlikely to hyperactivate and desensitize LPHN1. These cells 
expressed LPHN1 well and partially cleaved it into NTF and CTF (Fig. 2H, lanes 3, 5). As these 
cells did not glycosylate the NTF very efficiently, both glycosylated and un-glycosylated NTF 
forms could be detected (open arrowheads). The cleaved CTF appeared as a single band of 
65 kDa (black arrowhead). In addition, the cells accumulated the uncleaved, full-size LPHN1 
(black arrow, LPHN1-FS), which is not normally delivered to the cell surface7,33. To test for CTF 
phosphorylation, we incubated COS7 cells expressing LPHN1 with [32P]orthophosphate, 
overnight (Fig. 2H, lanes 1, 2). As a result, both the cleaved CTF and even the LPHN1-FS 
became phosphorylated (Fig. 2H, lane 1). In addition, a few other phosphorylated proteins were 
21 
detected (asterisks, lane 1), but they also appeared in cells transfected with an empty vector 
(asterisks, lane 2) and thus represented endogenous phosphorylated proteins. Thus, LPHN1 
is spontaneously phosphorylated in both neuronal and non-neuronal cells, even before it is 
delivered to the cell surface, which supports the idea that at least its basal phosphorylation is 
not linked to its desensitization as a GPCR.  
CTF phosphorylation map 
To date, no experimental data about CTF phosphorylation in LPHN1 has been published. 
Therefore, we used several online resources to predict potential sites in the cytosolic loops and 
C-terminal tail of the CTF. From 30 to 50 potential phosphorylation sites were identified (Fig. 
3A) as substrates for a large number of protein kinases: Ca2+-calmodulin-dependent protein 
kinase II, caseine kinases 1 and 2, cyclin-dependent kinase 1 CDK1/CDK2, DNA-activated 
protein kinase, glycogen synthase kinase 3, insulin receptor – tyrosine kinase, p38 mitogen-
activated protein kinase, protein kinase A, protein kinase C, protein kinase G, proto-oncogene 
tyrosine-protein kinase Src, and ribosomal s6 kinase. While some of these kinases are unlikely 
to phosphorylate LPHN1 because they localize in different cellular compartments (e.g. cdc2 is 
a nuclear protein, whereas LPHN1 is located in synapses), notably, no sites for GPCR kinases 
(GRKs), which are likely to phosphorylate LPHN1, were identified by any resource. In general, 
sequence-based phosphorylation site prediction appeared relatively unreliable: up to 30% of 
the phosphorylation sites assigned by different prediction tools did not coincide with each other, 
and most algorithms predicted some phosphorylation even in the NTF and extracellular loops 
of the CTF, which, while not entirely impossible, is highly unusual for a GPCR.  
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High-throughput tandem mass spectrometry (MS2), being based on phosphopeptide 
enrichment and peptide size determination, provides a somewhat more likely phosphorylation 
site assignment36. This method identifies 34 possible phosphorylation sites in the CTF (Fig. 
3A). By only selecting those phosphorylation sites that have been predicted in more than 5 
references38–45, it is possible to limit the number of predicted phosphorylation sites to 7 most 
likely positions (Fig. 3B). The majority of these sites are located in the distal part of the C-
terminal cytoplasmic tail, far from the cytosolic surface of the 7TMRs and are likely to affect 
CTF interactions with other proteins. Given this uncertainty about the number and positions of 
phosphorylated residues in the CTF, which made CTF mutagenesis approach inefficient, we 
decided to continue with pharmacological analysis of CTF phosphorylation. 
α-LTX chromatography causes CTF dephosphorylation  
To begin to understand the physiological role of CTF phosphorylation and to identify the 
enzymes involved in its regulation, we first analyzed how LPHN1 is distributed among 
sequentially purified brain membrane fractions46: (a) total brain homogenate (TB), (b) P1 pellet 
obtained by TB centrifugation (nuclei and broken cell bodies); (c) S1 supernatant obtained by 
TB centrifugation (post-nuclear membranes devoid of nuclei and neuronal cell bodies, but 
containing severed nerve terminals, fragments of axons, dendrites, mitochondria, somal 
vesicles, and somal cytosol), (d) P2 pellet obtained by S1 centrifugation (same as S1, but 
devoid of somal vesicles and cytosol); (e) synaptosomes purified from P2 by density gradient 
centrifugation (highly enriched nerve terminals containing small amounts of attached 
postsynaptic membrane; free from axonal and dendritic fragments), and (f) synaptic plasma 
membranes (SPM) obtained from synaptosomes by osmotic lysis (same as synaptosomes, but 
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free from presynaptic cytosol and vesicles). These membrane fractions were equalized for the 
amount of protein, separated by SDS-PAGE, and immunoblotted for both NTF and CTF. As 
demonstrated in Fig. 4A, both the NTF and CTF were present in all membrane fractions, except 
P1 (nuclei and cell bodies), but were strongly concentrated in synaptosomes and especially in 
SPM. Fractions discarded in the process of SPM purification (cell bodies, dendrites, axons) 
contained essentially no LPHN1 (Fig. 4A, P1; and not shown). This means that mature LPHN1 
is a synaptic protein and should be a substrate for synaptic kinases and phosphatases. 
These experiments led to an unexpected observation that the relative amounts of CTF bands 
differed among the membrane fractions. Thus, S1 contained a small proportion of the basally 
phosphorylated CTF-a, but a large amount of the fully phosphorylated CTF-d, while 
synaptosomes were rich in CTF-a, but had little CTF-d (Fig. 4A, B). This relationship remained 
when another detergent was used to solubilize the membranes (Fig. 4A, CHAPS), and thus did 
not depend on the efficiency of protein solubilization. This was puzzling, because all LPHN1 
present in S1 came from the SPM compartment, so theoretically the staining in S1 should have 
been the same as in SPM. These results suggested that differential dephosphorylation of CTF 
occurred after sample solubilization and that it could be mediated by different phosphatases 
present in distinct membrane fractions. Indeed, when the membranes were solubilized in the 
presence of exogenous PPIs, the CTF bands appeared the same in all fractions (Fig. 4C). This 
result suggested that during the solubilization of synaptosomes and SPM, some CTF was 
dephosphorylated and converted to CTF-a, which did not happen upon S1 solubilization.  
These findings called for a careful analysis of how the membranes affect CTF phosphorylation. 
To study LPHN1 fragments, we purified them from different membrane fractions using an α-
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LTX affinity column2, as shown above (Figs. 1, 2). While α-LTX only binds NTF7, the CTF co-
purifies with it, because the two fragments strongly interact via the N-terminal peptide of the 
CTF (Stachel peptide)7,11. Both the NTF and CTF always co-purified from S1 (Fig. 4D). 
However, surprisingly, practically no CTF was isolated with the NTF from synaptosomes and 
SPM (Fig. 4D). On average, only 10% of CTF was co-purified with the NTF from synaptosomes 
and SPM compared to S1 (Fig. 4E). Furthermore, the CTF from synaptosomes and SPM was 
largely dephosphorylated (Fig. 4D, Syn, SPM). As the starting membranes (S1, synaptosomes 
and SPM) contained similar amounts of CTF, which was also similarly phosphorylated (Fig. 
4C), this dephosphorylation and loss of CTF could only be explained by the effect of α-LTX 
chromatography.  
To ascertain that CTF dephosphorylation occurred during affinity chromatography, we carried 
out LPHN1 isolation in the presence of exogenous PPIs. As expected, this prevented CTF 
dephosphorylation (Fig. 4F). Surprisingly, the presence of PPIs also prevented the loss of CTF 
from the column, and LPHN1 purified from Syn, SPM and S1 contained the same amount of 
CTF (Fig. 4F). We hypothesized that CTF dephosphorylation leads to its loss. To demonstrate 
this, we carried out LPHN1 isolation from solubilized S1 membranes treated with alkaline 
phosphatase. Under these conditions, almost no CTF was co-purified with the NTF from S1 
(Fig. 4G), similar to synaptosomes and SPM. This confirmed that the dephosphorylated CTF 
was lost during affinity chromatography. 
We then asked whether this effect was caused specifically by affinity chromatography on α-LTX 
or any other protein that can bind LPHN1. When affinity chromatography of solubilized 
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synaptosomes was carried out using WGA as an adsorbent, no dephosphorylation or loss of 
CTF was observed (Fig. 4H). 
This meant that α-LTX attached to the chromatography column either caused CTF 
dephosphorylation by itself or exposed CTF to another component that was also able to bind 
α-LTX. This idea was tested by varying the relative amounts of the α-LTX column and the 
solubilized membranes loaded onto it (termed here “differential load affinity chromatography”). 
The rational was that if a α-LTX-column was overloaded with LPHN1, then it would not have 
the capacity to bind any other proteins that interact with toxin weaker than LPHN1. Reciprocally, 
if a large excess of α-LTX-column was used, it would provide sufficient binding sites not only 
for LPHN1, but also for any protein/s that could mediate CTF dephosphorylation. However, if 
α-LTX itself was responsible for CTF dephosphorylation, by direct contact with LPHN1, then 
under both conditions all CTF would be equally dephosphorylated (and lost). When such 
experiments were conducted, the results (quantified in Fig. 4I, examples shown in Fig. 5A) 
demonstrated that using a large LTX column (“>LTX”) led to much deeper CTF 
dephosphorylation than overloading a LTX column with LPHN1 (“>LPH”). This directly 
suggested that during affinity chromatography the excess of α-LTX on a large column provided 
binding sites for some phosphatase/s, which thus came into contact with the CTF and caused 
its dephosphorylation. In fact, at least one phosphatase, RPTPσ, is known to interact with 
LTX47. A direct experiment demonstrated that RPTPσ was indeed co-purified with LPHN1 on 
large LTX columns, but not on small LTX columns overloaded with LPHN1 (Fig. 4J).  
Thus, considered together, our results indicated that the CTF of LPHN1 was dephosphorylated 
during the incubation with α-LTX and that this reaction was mediated by brain phosphatases 
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(in particular RPTPσ) recruited to LPNH1 by α-LTX, but not by WGA. The differential 
dephosphorylation of the CTF by various fractions of brain membranes suggested that they 
might contain distinct sets of endogenous phosphatases and endogenous PPIs, which would 
differentially affect the CTF during chromatography (see also Discussion).  
Dephosphorylated CTF has a low affinity for the NTF 
The results described above could explain CTF dephosphorylation during α-LTX affinity 
chromatography, but not its loss from column eluates. Several processes could lead to the 
disappearance of dephosphorylated CTF: (1) the loss of phosphate groups could destabilize 
the CTF and facilitate its proteolytic degradation; (2) it could irreversibly aggregate; or (3) it 
could be eluted from the column in earlier fractions.  
As demonstrated above (Figs. 2D, E), dephosphorylation did not increase CTF degradation, 
but did cause some CTF aggregation. Although we could not exclude aggregation as one of 
the reasons behind the apparent loss of CTF, the aggregation never involved as much 
monomeric CTF as was lost in experiments with synaptosomes and SPM (compare Figs. 2B, 
D with Figs. 4D, G); in addition, treating α-LTX columns with SDS did not elute any aggregated 
CTF. Therefore, we carefully tested all fractions obtained during α-LTX-chromatography of 
solubilized synaptosomes, using the differential load affinity chromatography approach, as 
described in the previous section (Figs. 4I, J). When the amount of LTX on the column 
exceeded the amount of loaded LPHN1, we observed substantial dephosphorylation of CTF 
after overnight incubation (Fig. 5A, >LTX). Importantly, a large amount of CTF-a produced by 
dephosphorylation in this experiment appeared in the wash, where NTF was absent (Fig. 5A, 
>LTX). In contrast, when the loaded LPHN1 exceeded LTX on the column, no CTF 
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dephosphorylation, nor loss, occurred (Fig. 5A, >LPH). Quantification of these data (Fig. 5B), 
demonstrated a large and statistically highly significant loss of CTF from the final eluate under 
the LTX excess condition, compared to the LPH excess condition (Fig. 5B, Eluate). On the 
other hand, when the amount of CTF present in all fractions (including 0.5 M NaCl washes) was 
combined, no significant difference between the two conditions was observed (Fig. 5B, All 
fractions). These results showed that when the CTF was dephosphorylated on an α-LTX 
column, a large proportion of it dissociated from the NTF, while the latter remained bound to α-
LTX.  
The release of dephosphorylated CTF could be caused by (1) a weaker interaction between 
the NTF and dephosphorylated CTF or (2) a conformational change induced by α-LTX in the 
NTF that repelled the CTF. In addition, a direct role of α-LTX in CTF dephosphorylation was 
not entirely excluded by our differential load experiments above (Figs. 4I, J; 5A). One way to 
test all these possibilities was to separate purified LPHN1 on a different affinity column, for 
example WGA. This lectin binds the NTF of LPHN1, but does not cause receptor activation or 
separation of its fragments9, like α-LTX does. On the other hand, WGA does not interact with 
the CTF, which is not glycosylated (Fig. 2A). For this experiment (schematically shown in Fig. 
5C), we used LPHN1 purified on an α-LTX-column, which had been overloaded with S1 in the 
presence of exogenous PPIs to avoid any possible CTF dephosphorylation. This sample was 
then separated under three different conditions (Fig. 5C): (1) WGA-affinity chromatography of 
LPHN1 without any further treatment; (2) WGA-chromatography of LPHN1 treated with alkaline 
phosphatase to mimic CTF dephosphorylation on a column; and (3) second α-LTX affinity 
chromatography of untreated LPHN1. Using the eluate from a LTX column (Fig. 5C, D) had an 
additional advantage that it was devoid of any cellular protein phosphatases. In experiment 1, 
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both the NTF and all phosphorylated forms of CTF co-purified in the SDS eluate (Fig. 5E, 
Eluate). No CTF dephosphorylation occurred on this column and no CTF was present in wash 
fractions (Fig. 5E, Wash). When the receptor had been treated with alkaline phosphatase 
(experiment 2), both the NTF and CTF-a were seen binding to WGA-column, but about 90% of 
the CTF was then gradually released from the column by successive 0.5 M NaCl washes (Fig. 
5F, Wash). Only about 10% of the original CTF-a remained attached to the NTF and was eluted 
by SDS (Fig. 5F, Eluate). In experiment 3, the purified LPHN1 did not become 
dephosphorylated on a second α-LTX-column and was isolated without losses (Fig. 5G).  
These data indicated that CTF dephosphorylation during its purification from synaptic 
membranes (e.g. Fig. 4D, G, J) was mediated by cellular protein phosphatases rather than by 
a ligand (α-LTX or WGA) attaching to the NTF. Also, dephosphorylation of CTF apparently 
made the NTF-CTF complex less stable, leading to CTF release from the NTF by high salt 
washes. Finally, given the result in Fig. 5G, α-LTX binding to the NTF did not itself induce the 
release of phosphorylated CTF.  
However, the problem with these data was that they were based on NTF binding to a column. 
Although the column material seemed to have no direct effect on CTF dephosphorylation or 
loss, it was still possible that the specific configuration of the NTF-CTF complex attached to a 
column could artificially affect its stability. To test this hypothesis, we used an opposite 
approach and assessed NTF-CTF complex stability by attaching it to an adsorbent via the CTF. 
For this purpose, we used anti-CTF antibodies bound to a protein A column to pull down the 
CTF. The CTF was either intact or treated with alkaline phosphatase. We then measured co-
precipitation of the NTF with the CTF (Fig. 5H). The results of this experiment are shown in 
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Figs. 5I, J, where it can be seen that dephosphorylated CTF pulled down much less NTF than 
the fully phosphorylated control CTF. Thus, the stability of the NTF-CTF complex depends on 
the state of CTF phosphorylation and not on the manner in which it is pulled down.  
CTF dephosphorylation in tissues and cells  
These in vitro studies led to an important question whether ligand binding to the NTF could also 
affect CTF dephosphorylation in cells/tissues. We, therefore, compared αLTX-induced CTF 
phosphorylation and dephosphorylation in synaptosomes and neuroblastoma NB2a cells stably 
expressing LPHN1. The treatment of synaptosomes with 5 nM α-LTX for 1 h led to deep 
dephosphorylation of CTF (Fig. 6A). When LPHN1 was expressed in NB2a cells, its CTF 
migrated on SDS-gel as a series of bands resembling the basally phosphorylated CTF-a band 
and some highly phosphorylated CTF-b,c,d bands (Fig. 6B, bracket). To prove that this 
migration pattern reflected CTF phosphorylation, LPHN1 was isolated from NB2a cells using α-
LTX chromatography and treated with alkaline phosphatase. As demonstrated in Fig. 6B, left, 
dephosphorylation clearly removed the slower migrating CTF bands and also caused some 
CTF dimer formation. When these NB2a cells were treated with 5 nM α-LTX for 1 h, the amount 
of CTF-d slightly decreased, while CTF-a increased, and a small amount of dimer formation 
was detected. However, the treatment of the cells with a high α-LTX concentration (30 nM) led 
to strong dephosphorylation of the CTF and formation of a significant amount of SDS-resistant 
complexes (CTF dimers and trimers) (Fig. 6B, arrowheads 2, 3).  
These results indicated that α-LTX binding to the NTF could induce CTF dephosphorylation 
and dimerization by acting across the plasma membrane of living cells. Thus, the toxin could 
only cause CTF dephosphorylation if it recruited a phosphatase to the α-LTX-LPHN1 complex. 
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As was shown above (Fig. 4J), RPTPσ, which binds α-LTX, is one of the phosphatases that 
could participate in this reaction. We therefore analyzed the level of RPTPσ mRNA in the NB2a 
cells expressing LPHN1 (Fig. 6C). The amount of RPTPσ transcript was normalized to the 
mRNA level of β-actin, a housekeeping protein frequently used as a reference, and compared 
to the expression of two important proteins, stromal interacting molecules (STIM1 and 2), that 
are expressed in essentially all cells and participate in Ca2+ homeostasis. The level of RPTPσ 
mRNA exceeded that for STIM1 and 2 by a factor of 2 (Fig. 6D), suggesting that this 
phosphatase was actively produced by the neuroblastoma cells and could indeed mediate the 
effect of α-LTX on CTF dephosphorylation.  
To test whether the basally phosphorylated CTF-a had a low affinity for the NTF not only in 
vitro, but also in vivo, and to avoid any direct effect of α-LTX on the NTF, we separated 
solubilized brain membranes (S1) by sucrose density gradient centrifugation. This method also 
allowed an estimation of the molecular size and stoichiometry of the NTF-CTF complexes (Fig. 
6E, F). To calibrate the gradients and compare receptor preparations after different treatments, 
we also centrifuged several marker proteins (Fig. 6D) and SDS-denatured receptor (Fig. 6E, F, 
bottom panels).  
We found that in untreated membrane samples, the distribution of the NTF paralleled that of 
the phosphorylated CTF-b,c,d bands, demonstrating mostly stoichiometric dimeric complexes 
(LPH*2) (370 kDa) and also some tetramers (LPH*4) (740 kDa), but almost no monomers (185 
kDa) (Fig. 6E, F, top panels). This suggested that the phosphorylated forms of the CTF 
interacted with the NTF. However, most significantly, the basally phosphorylated CTF-a form 
trailed behind the NTF/CTF complexes (Fig. 6E; top panel, arrow). The position of the CTF-a 
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on the gradient indicated that it was dimeric, but there was no NTF in these fractions (Fig. 6F, 
insets).  
When the native NTF-CTF complexes were centrifuged in the presence of an excess of α-LTX 
(Fig. 6E, F, middle panel, grey line), the NTF and CTF shifted to a denser region of the gradient, 
with molecular masses of 630 kDa and above, corresponding to a complex of LPHN1 dimers 
with LTX dimers (LPH*2-LTX*2) (Fig. 6E, F). Importantly, some amount of dephosphorylated 
CTF-a trailed in the lighter gradient fractions, suggesting that, due to a lack of NTF, it did not 
participate in α-LTX-induced NTF-CTF complex. These data indicate that LPHN1 is dimeric in 
neuronal membranes and contains almost only the phosphorylated CTF-b,c,d bands. The 
basally phosphorylated/dephosphorylated CTF-a appears to form dimeric complexes that lack 
NTF.  
Discussion 
Based on technical improvements in electrophoretic separation of spontaneously aggregating 
CTF (Fig. 1) and on the use of alkaline phosphatase with or without PPIs (Fig. 2), we show 
here, for the first time, that the CTF of LPHN1 is post-translationally modified by both reversible 
phosphorylation and possibly palmitoylation (Fig. 2). Possible phosphorylation of LPHN1 has 
been previously mentioned in several reviews48–50, including a very comprehensive literature 
analysis51, but, to our knowledge, never experimentally addressed (except using MS2-based 
predictions, see below). However, phosphorylation of GPCRs is very important for their 
functions26,51 and, therefore, deserves an in-depth investigation. Many of the findings made in 
this paper will be directly applicable to other Adhesion GPCRs.  
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Theoretical predictions suggest that CTF of LPHN1 can be phosphorylated on ~ 50 sites that 
can serve as substrates for various kinases. Based on high-throughput MS2, 34 peptides have 
been identified as potentially phosphorylated and tentatively assigned to LPHN136 (Fig. 3A), 
with 5 potential sites in the cytosolic loops 2 and 3, and a large number in the C-terminal tail. 
Of the 34 potentially phosphorylated peptides, 7 sequences have been identified between 5 
and 86 times, suggesting that they are likely to be present in the CTF of LPHN1. However, it 
must be stressed that the MS2 assignment is still probabilistic, and none of these 34 peptides 
has been confirmed by sequence analysis. Four of the 7 most frequently hit peptides are not 
recognized as likely phosphorylation sites by any consensus sequence prediction algorithms, 
and the MS2 method regularly predicts multiple phosphorylation sites in the extracellular 
domains of LPHN1. Our experimental data agree with a relatively low number of 
phosphorylation sites, which involve Tyr, Ser, and Thr and appears as 4 protein bands that 
have different mobilities on the SDS-gels (Fig. 1A; 2F). This suggests that 7-10 phosphate 
groups can be attached to the slow-migrating CTF-d. This multi-site phosphorylation resembles 
the “barcode” type of phosphorylation by GRKs observed in many GPCRs26,52. Given the large 
number of potential phosphorylation sites in LPHN1, experimental analysis of its CTF 
phosphorylation is now required.  
What could be the functional role of this phosphorylation? The most interesting feature of CTF 
phosphorylation is that it leads to a change in CTF affinity for the NTF (Fig. 4-6): the 
phosphorylated CTF binds the NTF much stronger than the basally phosphorylated or 
dephosphorylated CTF. CTF phosphorylation in the brain, where LPHN1 expression by far 
exceeds its expression in any other tissues, apparently occurs prior to its normal function in 
synapses. Indeed, CTF is phosphorylated when LPHN1 is transiently expressed in COS and 
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NB2a cells (Figs. 2H, 6B), even before the protein is cleaved and delivered to the cell surface 
(Fig. 2H).  
In a vast number of receptors, ligand-induced phosphorylation, especially by GRKs, is 
associated with a decrease in ligand affinity, increased receptor desensitization and 
internalization27,53–56. However, LPHN1 (as an Adhesion GPCR) is unusual because it consists 
of two fragments, of which the NTF is engaged in strong cell-surface interactions with other 
proteins across the synaptic cleft12,57. Unless the NTF is proteolytically cleaved, its 
internalization is not possible. As phosphorylated CTF binds strongly to the NTF, it would also 
be unable to internalize. In addition, the CTF and the whole LPHN1 are unlikely to undergo the 
lysosomal pathway of internalization, because this would lead to their retrograde transport to 
neuronal somata58,59, and LPHN1 fragments are not observed in the P1 (Fig. 4A) or cytosolic 
vesicular fractions (not shown). Therefore, CTF desensitization and recovery probably occur 
while it remains in the plasma membrane, without internalization. On the other hand, the 
recycling of phosphate groups in highly phosphorylated CTF species is slow, constituting no 
more than 16% per hour. (Fig. 2). Finally, given that up to 100% of LPHN1 in nerve terminals 
is variously phosphorylated, the phosphorylated CTF must be an active form of LPHN1 rather 
than desensitized and destined for recycling, as in the case of GRK-phosphorylated GPCRs.  
On the other hand, similar to some other GPCRs60, differently phosphorylated LPHN1 forms 
can have distinct activities. In fact, the binding of LTXN4C, to the NTF causes NTF-CTF 
association and massive activation of the CTF7. The effect of LTXN4C can continue for hours in 
a burst-like manner, without showing any signs of desensitization61. However, activation by α-
LTX also leads to CTF dephosphorylation by cellular protein phosphatases (Figs. 4D, E, G, J; 
34 
5A; 6A, B), including RPTPσ, in a process that is schematically presented in Fig. 7. As a result, 
CTF affinity for the NTF decreases and it can dissociate from the complex (Fig. 5A, F, I; 6E). 
This obviously should stop the signaling induced by α-LTX, which only interacts with the NTF. 
However, it is tempting to speculate that this separation leads to a change in signaling specificity 
of LPHN1. Indeed, when LTXN4C acts via the NTF-CTF complex, it clearly stimulates Gαq-
mediated signaling via PLC to internal Ca2+ stores20,62. On the other hand, the CTF of LPHN1 
expressed without the NTF demonstrates a different signaling specificity and (at least when it 
is stimulated by exogenous Stachel peptide) activates Gαi, leading to a decrease in cAMP 
levels63. Thus, the activation of one signaling pathway may cause the CTF to dissociate from 
the complex and switch to another signaling pathway, where the CTF could act as a non-
Adhesion GPCR. In this process, the NTF would play the role of a molecular switch. CTF 
phosphorylation might also regulate its interaction with intracellular partners. Therefore, it is 
important to use phosphorylated forms of CTF when modeling its interaction with other proteins. 
Based on our data, LPHN1 appears to be always phosphorylated in synaptic membranes and 
in transfected cells (Figs. 1A, 2A, H; 6B) and remains largely phosphorylated even after long 
incubation in detergent extracts (Fig. 4A). However, both nerve terminals and NB2a cells 
contain RPTPσ and other phosphatases, which could theoretically dephosphorylate LPHN1, 
especially in detergent lysates. The stability of CTF phosphorylation could be explained by an 
equilibrium between the activities of phosphatases and kinases. However, CTF exchanges 
phosphate groups rather slowly (Fig. 2G); in addition, dephosphorylation does not prevail even 
after overnight incubations in detergent lysate (e.g. Fig. 4H), when ATP required for 
phosphorylation should be gradually lost. Thus, constant phosphorylation and 
dephosphorylation of LPHN1 is unlikely. It is thus possible that synaptic phosphatases that 
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target LPHN1 are normally inhibited and only slightly dephosphorylate the CTF (Fig. 4A). 
Alternatively, LPHN1 may normally exist in a conformation that does not allow its 
dephosphorylation. In fact, when α-LTX is added to solubilized membranes (in Sepharose-
immobilized form, Fig. 4D, G, J) or to synaptosomes and cells (in its soluble form, Fig. 6A, B), 
this leads to deep CTF dephosphorylation, possibly because α-LTX activates both LPHN1 and 
phosphatases, especially RPTPσ, which also binds α-LTX47 (Fig. 4J). Given that WGA, which 
also binds LPHN1, does not cause LPHN1 dephosphorylation after overnight incubation (Fig. 
4H), it is probable that LPHN1 dephosphorylation requires the activation of both LPHN1 and 
possibly phosphatase/s by an agonist (e.g. α-LTX).  
The purified neuronal compartments that normally contain LPHN1 (synaptosomes and SPM) 
have active phosphatases that dephosphorylate LPHN1 either spontaneously (albeit weakly) 
(Fig. 2A) or after activation by α-LTX (Figs. 4, 5A). One peculiar observation made here is that 
when these neuronal compartments are “contaminated” with components of neuronal cell 
bodies (TB or S1 fractions), which themselves lack LPHN1 (Fig. 4A), this leads to a strong 
inhibition of CTF dephosphorylation, whether spontaneous or α-LTX-mediated (Fig. 4A, D). 
This suggests that endogenous PPIs (probably regulatory subunits of protein phosphatases) 
are more abundant in the TB or S1 fractions than any protein phosphatases in nerve terminals. 
These “contaminating” PPIs, present in the somal cytosol or fragments of the endoplasmic 
reticulum, could ectopically inhibit CTF dephosphorylation by synaptic phosphatases when they 
areactivated by solubilization or by α-LTX. On the other hand, PPIs present in synapses are 
unable to protect CTF from α-LTX-induced dephosphorylation, probably because α-LTX brings 
the CTF and RPTPσ (and other phosphatases) into close apposition. An interaction of α-LTX 
with its two receptors (RPTPσ and LPHN1) could be the mechanism by which α-LTX 
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dephosphorylates the CTF and so efficiently signals via LPHN1 (Fig. 7). However, given that 
CTF is phosphorylated not only on Tyr, but also Ser and Thr, it is clear that RPTPσ is not the 
only phosphatase targeting LPHN1. 
Finally, as dephosphorylation weakens the CTF-NTF interaction (Figs. 4, 5), it is important to 
consider this hypothesis in light of the ability of LPHN1 fragments to dissociate and re-associate 
reversibly, as described previously7,8 and later independently confirmed using another 
Adhesion GPCR64. This dissociation and especially association have been a contentious issue, 
especially considering the 3D structure of the LPHN1 GAIN domain11, which demonstrates that 
the Stachel peptide is essentially buried in the C-terminal part of the NTF, making it hard to 
imagine how the two could separate, let alone reassemble afterwards. However, the 
dissociation-association was observed only on the cell surface and not when the NTF and CTF 
were expressed as soluble proteins7,8,64. It is possible that the anchoring mechanism, which 
holds the NTF on the membrane, also helps to maintain an open cavity within the GAIN domain, 
which allows the CTF docking/undocking. Alternatively, it is possible that the reassociation does 
not fully restore the tight grasp of the Stachel peptide by the GAIN domain11. The two LPHN1 
fragments might interact in many different ways, but it is clear that α-LTX binding to the NTF 
leads to its reassembly with the CTF on the cell membrane, allowing LPHN1 to mediate an 
intracellular signal7,8,64, and CTF dephosphorylation could be involved in generating this signal. 
In conclusion, we propose that the strength of NTF-CTF interaction is based on the 
phosphorylation state of the CTF and this may affect the physiological functions of LPHN1. 
Previously, we described the dynamic nature of NTF-CTF interaction7,8. This paper reveals the 
first details of how this interaction may be regulated in cells. Other Adhesion GPCRs may be 
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subject to similar modulation, and it will be important to study these processes in other members 
of this family.  
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Figure 1. Analysis of the CTF of LPHN1 by SDS-PAGE. A. LPHN1 isolated on an α-LTX 
column from rat brain S1 membranes was separated in an 8% SDS-gel (conditions indicated 
at the top), and immunoblotted with antibodies against the NTF or CTF (shown at the bottom). 
Inset, electrophoretic separation of the CTF into 4 bands. B. Computer-aided densitometry of 
the CTF bands. Black line, an average profile; blue bars, standard deviation. C. Immunoblotting 
of brain membranes from wild-type and LPHN1 knockout (KO) mice for neurexin Iα (NRXN1), 
NTF and CTF. Arrowhead shows a lack of CTF staining in the KO brain. The numbers of 
independent experiments (n) were: A, 5; B, 6; C, 4. 
Figure 2. The CTF of LPHN1 is phosphorylated on several sites. A. LPHN1 purified from 
S1 rat brain membranes on α-LTX was treated with neuraminidase and PNGase F or O-
glycosidase, separated by SDS-PAGE and immunoblotted using affinity-purified antibodies 
against NTF and/or CTF. Inset, extended SDS-PAGE of LPHN1 in a 4% SDS-gel, 
immunoblotted for NTF. B. α-LTX-purified LPHN1 (left) or crude S1 membranes (right) were 
incubated with alkaline phosphatase (AP), in the absence or presence of exogenous PPIs. C. 
Computer-aided densitometry of the purified LPHN1 before (control) and after (AP) treatment 
with alkaline phosphatase. D. LPHN1 purified or from rat S1 membranes was treated with 
increasing doses of AP and hydroxylamine in the order shown. Right, a larger image of the 
blots showing lanes 2 and 3 to demonstrate that dephosphorylation of CTF induced its 
aggregation, but not degradation. Detergent extract from COS7 cells transiently transfected 
with LPHN1 was used as a marker of the dephosphorylated CTF. E. Quantification of all CTF-
stained monomers and aggregates before (No AP) and after (AP) treatment with alkaline 
phosphatase. F. Purified LPHN1 treated (+) or untreated (–) with alkaline phosphatase was 
immunoblotted with antibodies against phosphorylated amino acids. G. Lanes 1, 2: 
synaptosomes (Syn) were incubated with 32P orthophosphate, solubilized and used to isolate 
LPHN1, which was separated by SDS-PAGE, transferred onto PVDF membrane and 
autoradiographed for 40 h. Lanes 3-5: the same blot as in lane 1 was immunostained for CTF 
and NTF; lane 4, long exposure. Lanes 6, 7: for comparison, purified LPHN1 was labeled with 
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125I, blotted and autoradiographed for 16 h. Lanes 2, 7: the electrophoretic samples were boiled 
for 5 min before loading on SDS-gels. Filled arrowheads, CTF and CTF dimer (2); open 
arrowhead, NTF; asterisk, a phosphorylated contaminant; arrow, aggregated CTF at gel top 
(Aggr.). H. COS7 cells transiently expressing LPHN1 (or empty vector) were [32P]-
phosphorylated, separated by SDS-PAGE, transferred onto membrane and exposed to an X-
ray film for 24 h (lanes 1, 2). The membrane was then immunostained for NTF and CTF (lanes 
3-6). 32P-labeled cellular proteins in control and LPHN1 cells are marked by asterisks. The 
immunoblot shows the uncleaved full-size LPHN1 (FS, black arrow), glycosylated (glyc.) and 
unglycosylated (unglyc.) NTF (open arrowheads) and the single CTF band (black arrowhead). 
Note that both the single CTF band and the FS LPHN1 are phosphorylated. The numbers of 
independent experiments (n) were: A, 4; B, 8/12; C, 8/12; D, 8; E, 8; F, 3; G, 3; H, 3. 
Figure 3. A map of predicted phosphorylation sites in the CTF. A. Phosphorylation sites 
predicted by high-throughput MS236 are indicated by circles, with the bar height proportional to 
the number of potential hits and the red color denoting sites with more than 5 hits. B. The 
positions and surrounding peptide sequences of the seven potentially phosphorylated residues 
(red circles in A); the predicted phosphorylated residues are encircled. The table also shows 
the number of theoretical hits and selected references reporting the predictions.  
Figure 4. The CTF is dephosphorylated by cytosolic protein phosphatases and is lost 
from NTF. A. Brain membrane fractions (P1; S1; synaptosomes, Syn; and SPM) were 
solubilized in Thesit or CHAPS (for comparison of solubilization efficiency) and immunoblotted 
for NTF and CTF. LPHN1 expressed in COS7 cells was used as a marker of NTF and CTF 
proteins (labeling as in Fig. 2H). B. Differential abundance of the basally phosphorylated CTF-
a (left) and maximally phosphorylated CTF-d (right) in respective brain membranes. t-Test with 
Bonferroni correction: *, p < 0.05. C. Inhibition of differential CTF dephosphorylation in the same 
membrane fractions by exogenous PPIs. D. CTF co-purifies with NTF on α-LTX columns from 
S1, but not from synaptosomes or SPM (two independent experiments with different exposure 
are shown). E. Quantification of CTF co-purifying with NTF on α-LTX-columns from respective 
membrane fractions. F. In the presence of exogenous PPIs, CTF co-purifies with NTF on α-
LTX columns from all membranes. G. Alkaline phosphatase-induced dephosphorylation of CTF 
in S1 blocks its co-purification with NTF. H. The CTF in solubilized synaptosomes is not 
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dephosphorylated and co-purifies with NTF on WGA-columns. I. Quantification of differential 
load affinity chromatography (example shown in Fig. 5A), in which the α-LTX column is either 
overloaded with an excess of LPHN1 in solubilized S1 membranes (>LPH) or is in excess over 
solubilized S1 (>LTX). t-Test with Bonferroni correction: ***, p < 0.001. J. Differential load α-
LTX-affinity chromatography with solubilized synaptosomes; the eluates are immunoblotted for 
NTF, CTF, and RPTPσ. The numbers of independent experiments (n) were: A, 3; B, 3; C, 6; D, 
5; E, 5; F, 6; G, 3; H, 3; I, 5; J, 3. 
Figure 5. The CTF dephosphorylation decreases its high affinity for the NTF. A. 
Differential load α-LTX-affinity chromatography of solubilized synaptosomes. CTF is 
dephosphorylated during chromatography under >LTX condition and is released from the 
column in wash fractions. Overloading α-LTX-columns with LPHN1 in solubilized membranes 
blocks CTF dephosphorylation and dissociation from NTF. B. Quantification of differentia load 
α-LTX-affinity chromatography experiments, as in A. t-Test with Bonferroni correction: **, p < 
0.01; ***, p < 0.001. C. A scheme of experiments with secondary affinity chromatography of 
purified LPHN1 on α-LTX or WGA-columns, with or without alkaline phosphatase treatment. D 
– G. LPHN1 purified on α-LTX from S1 membranes was chromatographed on a WGA-column 
(with or without alkaline phosphatase, AP) or on an α-LTX column. E, F. WGA-chromatography 
of purified LPHN1 in the absence (E) or in the presence (F) of AP. G. Secondary 
chromatography of purified LPHN1 on an α-LTX column, in the absence of AP. Note that CTF 
is not dephosphorylated in the absence of other synaptosomal proteins. H. A scheme of 
immunoprecipitation experiments with LPHN1 purified from solubilized S1, with or without 
treatment with alkaline phosphatase, as shown in I. I. LPHN1 purified from S1 on an α-LTX-
column was treated with or without alkaline phosphatase and immunoprecipitated using chicken 
anti-CTF antibodies and immunoblotted for CTF and NTF using respective rabbit antibodies. J. 
Quantification of experiments, as in I. The NTF yield in control experiments (No AP) taken as 
100%. t-Test: **, p < 0.01. The numbers of independent experiments (n) were: A, 5; B, 5; D, 21; 
E, 3; F, 3; G, 3; I, 5; J, 5. 
Figure 6. CTF dephosphorylation in cells and tissues. A. Synaptosomes were treated with 
5 nM α-LTX for 1 h with oxygenation, then solubilized, separated by SDS-PAGE and 
immunoblotted for α-LTX, NTF and CTF. B. Left: LPHN1 purified from transfected NB2a cells 
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was treated with alkaline phosphatase, separated by SDS-PAGE and immunoblotted for NTF 
and CTF. The CTF is phosphorylated, showing several differently migrating bands, which 
disappear on AP treatment. Right: LPHN1-expressing NB2a cells were incubated for 1 h with 
increasing amounts of α-LTX. α-LTX causes LPHN dephosphorylation and dimerization. C. RT-
PCR analysis of RPTPσ mRNA in LPHN1-expressing NB2a cells. β-Actin mRNA was used for 
normalization, STIM1 and STIM2 used for comparison. D. Calibration curve for sucrose density 
gradients, as shown in E, using molecular mass marker proteins: thyroglobulin, apoferritin, β-
amylase, α-LTX, aldolase, BSA. E. Rat brain membranes (S1) were solubilized in Thesit and 
centrifuged in sucrose density gradients, as described under Methods. The gradient fractions 
were separated by SDS-PAGE and immunoblotted for α-LTX (middle panel), NTF and CTF (3 
gels were used to separate each gradient). Top, untreated solubilized S1 membranes. Middle, 
solubilized S1 membranes centrifuged in the presence of a large excess of α-LTX. Bottom, 
solubilized S1 membranes centrifuged after treatment with 1% SDS and 100 mM DTT. F. 
Quantification of NTF and CTF distribution in gradient fractions (from E). Insets, LPHN1 at the 
bottom and top of gradient contains differentially phosphorylated CTF; only CTF is present in 
the top gradient fractions. The positions of predicted molecular species are shown at the top; 
the positions of molecular mass markers are shown in the bottom graph. The numbers of 
independent experiments (n) were: A, 4; B, 3; C, 4; D, 3; E, 3; F, 3. 
Figure 7. CTF phosphorylation/dephosphorylation and its role in the NTF-CTF 
interaction. LPHN1 on the cell surface is cleaved and multiply phosphorylated. Both LPHN1 
and RPTPσ are dimerized. Multimeric ligands (such as α-LTX, teneurin-2) can bring LPHN1 
and RPTPσ into close proximity, which would facilitate CTF dephosphorylation and formation 
of SDS-resistant CTF complexes, but weaken the NTF-CTF interaction. Other protein 




Figure 1. Analysis of the CTF of LPHN1 by SDS-PAGE. A. LPHN1 isolated on an α-LTX column from 
rat brain S1 membranes was separated in an 8% SDS-gel (conditions indicated at the top), and 
immunoblotted with antibodies against the NTF or CTF (shown at the bottom). Inset, electrophoretic 
separation of the CTF into 4 bands. B. Computer-aided densitometry of the CTF bands. Black line, an 
average profile; blue bars, standard deviation. C. Immunoblotting of brain membranes from wild-type 
and LPHN1 knockout (KO) mice for neurexin Iα (NRXN1), NTF and CTF. Arrowhead shows a lack of 




Figure 2. The CTF of LPHN1 is phosphorylated on several sites. A. LPHN1 purified from S1 rat brain 
membranes on α-LTX was treated with neuraminidase and PNGase F or O-glycosidase, separated by SDS-PAGE 
and immunoblotted using affinity-purified antibodies against NTF and/or CTF. Inset, extended SDS-PAGE of 
LPHN1 in a 4% SDS-gel, immunoblotted for NTF. B. α-LTX-purified LPHN1 (left) or crude S1 membranes (right) 
were incubated with alkaline phosphatase (AP), in the absence or presence of exogenous PPIs. C. Computer-
aided densitometry of the purified LPHN1 before (control) and after (AP) treatment with alkaline phosphatase. D. 
LPHN1 purified or from rat S1 membranes was treated with increasing doses of AP and hydroxylamine in the order 
shown. Right, a larger image of the blots showing lanes 2 and 3 to demonstrate that dephosphorylation of CTF 
induced its aggregation, but not degradation. Detergent extract from COS7 cells transiently transfected with 
LPHN1 was used as a marker of the dephosphorylated CTF. E. Quantification of all CTF-stained monomers and 
aggregates before (No AP) and after (AP) treatment with alkaline phosphatase. F. Purified LPHN1 treated (+) or 
untreated (–) with alkaline phosphatase was immunoblotted with antibodies against phosphorylated amino acids. 
G. Lanes 1, 2: synaptosomes (Syn) were incubated with 32P orthophosphate, solubilized and used to isolate 
LPHN1, which was separated by SDS-PAGE, transferred onto PVDF membrane and autoradiographed for 40 h. 
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Lanes 3-5: the same blot as in lane 1 was immunostained for CTF and NTF; lane 4, long exposure. Lanes 6, 7: 
for comparison, purified LPHN1 was labeled with 125I, blotted and autoradiographed for 16 h. Lanes 2, 7: the 
electrophoretic samples were boiled for 5 min before loading on SDS-gels. Filled arrowheads, CTF and CTF dimer 
(2); open arrowhead, NTF; asterisk, a phosphorylated contaminant; arrow, aggregated CTF at gel top (Aggr.). H. 
COS7 cells transiently expressing LPHN1 (or empty vector) were [32P]-phosphorylated, separated by SDS-PAGE, 
transferred onto membrane and exposed to an X-ray film for 24 h (lanes 1, 2). The membrane was then 
immunostained for NTF and CTF (lanes 3-6). 32P-labeled cellular proteins in control and LPHN1 cells are marked 
by asterisks. The immunoblot shows the uncleaved full-size LPHN1 (FS, black arrow), glycosylated (glyc.) and 
unglycosylated (unglyc.) NTF (open arrowheads) and the single CTF band (black arrowhead). Note that both the 
single CTF band and the FS LPHN1 are phosphorylated. The numbers of independent experiments (n) were: A, 




Figure 3. A map of predicted phosphorylation sites in the CTF. A. Phosphorylation sites predicted by high-
throughput MS236 are indicated by circles, with the bar height proportional to the number of potential hits and the 
red color denoting sites with more than 5 hits. B. The positions and surrounding peptide sequences of the seven 
potentially phosphorylated residues (red circles in A); the predicted phosphorylated residues are encircled. The 





Figure 4. The CTF is dephosphorylated by cytosolic protein phosphatases and is lost from NTF. A. Brain 
membrane fractions (P1; S1; synaptosomes, Syn; and SPM) were solubilized in Thesit or CHAPS (for comparison 
of solubilization efficiency) and immunoblotted for NTF and CTF. LPHN1 expressed in COS7 cells was used as a 
marker of NTF and CTF proteins (labeling as in Fig. 2H). B. Differential abundance of the basally phosphorylated 
CTF-a (left) and maximally phosphorylated CTF-d (right) in respective brain membranes. t-Test with Bonferroni 
correction: *, p < 0.05. C. Inhibition of differential CTF dephosphorylation in the same membrane fractions by 
exogenous PPIs. D. CTF co-purifies with NTF on α-LTX columns from S1, but not from synaptosomes or SPM 
(two independent experiments with different exposure are shown). E. Quantification of CTF co-purifying with NTF 
on α-LTX-columns from respective membrane fractions. F. In the presence of exogenous PPIs, CTF co-purifies 
with NTF on α-LTX columns from all membranes. G. Alkaline phosphatase-induced dephosphorylation of CTF in 
S1 blocks its co-purification with NTF. H. The CTF in solubilized synaptosomes is not dephosphorylated and co-
purifies with NTF on WGA-columns. I. Quantification of differential load affinity chromatography (example shown 
in Fig. 5A), in which the α-LTX column is either overloaded with an excess of LPHN1 in solubilized S1 membranes 
(>LPH) or is in excess over solubilized S1 (>LTX). t-Test with Bonferroni correction: ***, p < 0.001. J. Differential 
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load α-LTX-affinity chromatography with solubilized synaptosomes; the eluates are immunoblotted for NTF, CTF, 





Figure 5. The CTF dephosphorylation decreases its high affinity for the NTF. A. Differential load α-LTX-
affinity chromatography of solubilized synaptosomes. CTF is dephosphorylated during chromatography under 
>LTX condition and is released from the column in wash fractions. Overloading α-LTX-columns with LPHN1 in 
solubilized membranes blocks CTF dephosphorylation and dissociation from NTF. B. Quantification of differentia 
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load α-LTX-affinity chromatography experiments, as in A. t-Test with Bonferroni correction: **, p < 0.01; ***, p < 
0.001. C. A scheme of experiments with secondary affinity chromatography of purified LPHN1 on α-LTX or WGA-
columns, with or without alkaline phosphatase treatment. D – G. LPHN1 purified on α-LTX from S1 membranes 
was chromatographed on a WGA-column (with or without alkaline phosphatase, AP) or on an α-LTX column. E, 
F. WGA-chromatography of purified LPHN1 in the absence (E) or in the presence (F) of AP. G. Secondary 
chromatography of purified LPHN1 on an α-LTX column, in the absence of AP. Note that CTF is not 
dephosphorylated in the absence of other synaptosomal proteins. H. A scheme of immunoprecipitation 
experiments with LPHN1 purified from solubilized S1, with or without treatment with alkaline phosphatase, as 
shown in I. I. LPHN1 purified from S1 on an α-LTX-column was treated with or without alkaline phosphatase and 
immunoprecipitated using chicken anti-CTF antibodies and immunoblotted for CTF and NTF using respective 
rabbit antibodies. J. Quantification of experiments, as in I. The NTF yield in control experiments (No AP) taken as 
100%. t-Test: **, p < 0.01. The numbers of independent experiments (n) were: A, 5; B, 5; D, 21; E, 3; F, 3; G, 3; I, 




Figure 6. CTF dephosphorylation in cells and tissues. A. Synaptosomes were treated with 5 nM α-LTX for 1 h 
with oxygenation, then solubilized, separated by SDS-PAGE and immunoblotted for α-LTX, NTF and CTF. B. Left: 
LPHN1 purified from transfected NB2a cells was treated with alkaline phosphatase, separated by SDS-PAGE and 
immunoblotted for NTF and CTF. The CTF is phosphorylated, showing several differently migrating bands, which 
disappear on AP treatment. Right: LPHN1-expressing NB2a cells were incubated for 1 h with increasing amounts 
of α-LTX. α-LTX causes LPHN dephosphorylation and dimerization. C. RT-PCR analysis of RPTPσ mRNA in 
LPHN1-expressing NB2a cells. β-Actin mRNA was used for normalization, STIM1 and STIM2 used for comparison. 
D. Calibration curve for sucrose density gradients, as shown in E, using molecular mass marker proteins: 
thyroglobulin, apoferritin, β-amylase, α-LTX, aldolase, BSA. E. Rat brain membranes (S1) were solubilized in 
Thesit and centrifuged in sucrose density gradients, as described under Methods. The gradient fractions were 
separated by SDS-PAGE and immunoblotted for α-LTX (middle panel), NTF and CTF (3 gels were used to 
separate each gradient). Top, untreated solubilized S1 membranes. Middle, solubilized S1 membranes centrifuged 
in the presence of a large excess of α-LTX. Bottom, solubilized S1 membranes centrifuged after treatment with 
1% SDS and 100 mM DTT. F. Quantification of NTF and CTF distribution in gradient fractions (from E). Insets, 
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LPHN1 at the bottom and top of gradient contains differentially phosphorylated CTF; only CTF is present in the 
top gradient fractions. The positions of predicted molecular species are shown at the top; the positions of molecular 
mass markers are shown in the bottom graph. The numbers of independent experiments (n) were: A, 4; B, 3; C, 




Figure 7. CTF phosphorylation/dephosphorylation and its role in the NTF-CTF interaction. LPHN1 on the 
cell surface is cleaved and multiply phosphorylated. Both LPHN1 and RPTPσ are dimerized. Multimeric ligands 
(such as α-LTX, teneurin-2) can bring LPHN1 and RPTPσ into close proximity, which would facilitate CTF 
dephosphorylation and formation of SDS-resistant CTF complexes, but weaken the NTF-CTF interaction. Other 
protein phosphatases may also be involved.  
 
 
